The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 13, 2016

Filed:

May. 03, 2010
Applicant:

Roland Wolkowicz, San Diego, CA (US);

Inventor:

Roland Wolkowicz, San Diego, CA (US);

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C40B 30/06 (2006.01); C12N 9/50 (2006.01); C12Q 1/37 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C12N 9/506 (2013.01); C12Q 1/37 (2013.01); G01N 33/5076 (2013.01); C07K 2319/01 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C12N 2503/02 (2013.01); C12N 2510/00 (2013.01); G01N 2333/9513 (2013.01); G01N 2500/02 (2013.01); G01N 2500/10 (2013.01);
Abstract

The invention is directed to compositions to screen for small molecule drugs that inhibit proteases, such as viral proteases, e.g., HIV proteases; and methods for making and using these compositions. The invention provides compositions and methods for identifying compositions, e.g., drug molecules, that can inhibit proteases, e.g., HIV proteases. In alternative embodiments, the invention provides cell-based assays to screen for compositions, e.g., small molecules or drugs, that inhibit or modify the activity of enzymes such as calcium-dependent protein convertases involved in HIV envelop protein processing, including cleavage of the HIV gp160 envelope precursor, resulting in gp120 and gp41 envelope products.


Find Patent Forward Citations

Loading…